Loading...
Market
Will Sanofi's market cap increase within one month of the Opella stake sale announcement?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Stock market data, financial news outlets
Story
Sanofi Nears €15.5 Billion Sale of 50% Stake in Opella to CD&R
Oct 11, 2024, 04:44 AM
Sanofi is nearing a significant deal to sell a 50% controlling stake in its consumer health unit, Opella, to Clayton Dubilier & Rice (CD&R). The transaction, valued at approximately €15.5 billion ($16 billion), is poised to be one of the largest deals of the year. CD&R has reportedly outbid rivals, including a consortium led by PAI Partners, to secure this acquisition. The sale, estimated at €15 billion, is seen as a critical health check for mega leveraged buyouts (LBOs) and underscores the growing interest in the consumer health sector.
View original story
Similar markets
Yes • 50%
No • 50%
Increase by more than 10% • 25%
Increase by 5% to 10% • 25%
Increase by less than 5% • 25%
No increase or decrease • 25%
Yes • 50%
No • 50%
Stock price increases by over 10% • 25%
Stock price increases by 5-10% • 25%
Stock price changes less than 5% • 25%
Stock price decreases • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Increases by more than 50% • 25%
Increases by 25% to 50% • 25%
Changes by less than 25% • 25%
Decreases • 25%
